Skip to main content

Advertisement

SpringerLink
Log in

Immunomodulatory effects of vitamin D in peripheral blood monocyte-derived macrophages from patients with rheumatoid arthritis

  • Original Article
  • Published:
Clinical and Experimental Medicine Aims and scope Submit manuscript

Abstract

1,25-Dihydroxyvitamin D (1,25(OH)2D3), the active form of vitamin D, modulates both innate and adaptive immune responses. Emerging epidemiological data has also demonstrated disease-modifying and immunomodulatory effects of vitamin D in a wide range of human autoimmune diseases, including rheumatoid arthritis (RA). To evaluate in vitro effects of 1,25(OH) 2D3 in primary cultures of peripheral blood monocyte-derived macrophages of RA patients, monocyte/macrophages, isolated from peripheral blood mononuclear cells of RA patients and healthy subjects by exploiting their ability to adhere to plastic, were treated with increasing concentrations of 1,25(OH)2D3 for 48 h. TNF-α, IL-1 α, IL-1β, IL-6 and RANKL production was determined by ELISA and nitric oxide (NO) release using the Griess method. Immunocytochemistry analysis was also performed to evaluate alterations in transmembrane TNF-α expression after 1,25(OH) 2D3 treatment. A significant dose-dependent decrease in TNF-α and RANKL production by cultured RA macrophages after 1,25(OH)2D3 treatment was found, whereas a significant reduction in normal cells was observed only at higher concentrations. IL-1 α, IL-1β and IL-6 levels were reduced by 1,25(OH) 2D3 at higher concentrations in all cell populations. TNF-α immunostaining was less intense in treated cells compared with untreated. 1,25(OH) 2D3 significantly reduced NO levels regardless of the concentration used. Vitamin D downregulated proinflammatory mediators in monocyte-derived macrophages, and RA cells appeared more sensitive than normal cells. These effects further provide a rationale for the therapeutic value of vitamin D supplementation in the treatment for RA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Maruotti N, Cantatore FP. (2010) Vitamin D and the immune system. J Rheumatol 37(3):491–495 [Epub 2010 Jan 15]

    Google Scholar 

  2. Choy EH (2006) Joint inflammation and cytokine inhibition in rheumatoid arthritis. Clin Exp Med 6:13–19

    Article  PubMed  Google Scholar 

  3. Maruotti N, Cantatore FP, Crivellato E et al (2007) Macrophages in rheumatoid arthritis. Histol Histopathol 22:581–586

    Google Scholar 

  4. Mulherin D, Fitzgerald O, Bresnihan B (1996) Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum 39:115–124

    Article  CAS  PubMed  Google Scholar 

  5. Hummel KM, Petrow PK, Franz JK et al (1998) Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction. J Rheumatol 25:1887–1894

    CAS  PubMed  Google Scholar 

  6. Hou WS, Li W, Keyszer G et al (2002) Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium. Arthritis Rheum 46:663–674

    Article  CAS  PubMed  Google Scholar 

  7. Schulze-Koops H, Davis LS, Kavanaugh AF et al (1997) Elevated cytokine messenger RNA levels in the peripheral blood of patients with rheumatoid arthritis suggest different degrees of myeloid cell activation. Arthritis Rheum 40:639–647

    Article  CAS  PubMed  Google Scholar 

  8. Lioté F, Boval-Boizard B, Weill D et al (1996) Blood monocyte activation in rheumatoid arthritis: increased monocyte adhesiveness, integrin expression, and cytokine release. Clin Exp Immunol 106:13–19

    Article  PubMed Central  PubMed  Google Scholar 

  9. Lavagno L, Gunella G, Bardelli C et al (2004) Anti-inflammatory drugs and tumor necrosis factor-alpha production from monocytes: role of transcription factor NF-kappa B and implication for rheumatoid arthritis therapy. Eur J Pharmacol 501:199–208

    Article  CAS  PubMed  Google Scholar 

  10. Aletaha D, Neogi T, Silman AJ et al (2010) Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581

    Article  PubMed  Google Scholar 

  11. Rausch-Fan X, Leutmezer F, Willheim M et al (2002) Regulation of cytokine production in human peripheral blood mononuclear cells and allergen-specific th cell clones by 1alpha,25-dihydroxyvitamin D3. Int Arch Allergy Immunol 128:33–41

    Article  CAS  PubMed  Google Scholar 

  12. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3:1101–1108

    Article  CAS  PubMed  Google Scholar 

  13. Cantorna MT, Hayes CE, DeLuca HF (1996) 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci USA 93:7861–7864

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Cutolo M, Otsa K, Laas K et al (2006) Circannual Vitamin D serum levels and disease activity in rheumatoid arthritis: northern versus Southern Europe. Clin Exp Rheumatol 24:702–704

    CAS  PubMed  Google Scholar 

  15. Andjelkovic Z, Vojinovic J, Pejnovic N et al (1999) Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients. Clin Exp Rheumatol 17:453–456

    CAS  PubMed  Google Scholar 

  16. Cantorna MT, Hayes CE, DeLuca HF (1998) 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr 128:68–72

    CAS  PubMed  Google Scholar 

  17. Caporali R, Sarzi-Puttini P, Atzeni F et al (2010) Switching TNF-alpha antagonists in rheumatoid arthritis: the experience of the LORHEN registry. Autoimmun Rev 9:465–469

    Article  CAS  PubMed  Google Scholar 

  18. Atzeni F, Sarzi-Puttini P, Gorla R, Marchesoni A, Caporali R (2011) Switching rheumatoid arthritis treatments: an update. Autoimmun Rev 10:397–403

    Article  PubMed  Google Scholar 

  19. Alsalameh S, Winter K, Al-Ward R, Wendler J, Kalden JR, Kinne RW (1999) Distribution of TNF-alpha, TNF-R55 and TNF-R75 in the rheumatoid synovial membrane: TNF receptors are localized preferentially in the lining layer; TNF-alpha is distributed mainly in the vicinity of TNF receptors in the deeper layers. Scand J Immunol 49:278–285

    Article  CAS  PubMed  Google Scholar 

  20. Georgopoulos S, Plows D, Kollias G (1996) Transmembrane TNF is sufficient to induce localized tissue toxicity and chronic inflammatory arthritis in transgenic mice. J Inflamm 46:86–97

    CAS  PubMed  Google Scholar 

  21. Alexopoulou L, Pasparakis M, Kollias G (1997) A murine transmembrane tumor necrosis factor (TNF) transgene induces arthritis by cooperative p55/p75 TNF receptor signaling. Eur J Immunol 27:2588–2592

    Article  CAS  PubMed  Google Scholar 

  22. Kinne RW, Bräuer R, Stuhlmüller B et al (2000) Macrophages in rheumatoid arthritis. Arthritis Res 2:189–202

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. McInnes IB, Schett G (2007) Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 7:429–442

    Article  CAS  PubMed  Google Scholar 

  24. Obermeier F, Gross V, Schölmerich J (1999) Interleukin-1 production by mouse macrophages is regulated in a feedback fashion by nitric oxide. J Leukoc Biol 66:829–836

    CAS  PubMed  Google Scholar 

  25. Baugh JA, Donnelly SC (2003) Macrophage migration inhibitory factor: a neuroendocrine modulator of chronic inflammation. J Endocrinol 179:15–23

    Article  CAS  PubMed  Google Scholar 

  26. Zhang Y, Leung DY, Richers BN et al (2012) Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol 188:2127–2135

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. Rego D, Kumar A, Nilchi L, Wright K, Huang S, Kozlowski M (2011) IL-6 production is positively regulated by two distinct Src homology domain 2-containing tyrosine phosphatase-1 (SHP-1)-dependent CCAAT/enhancer-binding protein β and NF-κB pathways and an SHP-1-independent NF-κB pathway in lipopolysaccharide-stimulated bone marrow-derived macrophages. J Immunol 186:5443–5456

    Article  CAS  PubMed  Google Scholar 

  28. Geng Y, Zhang B, Lotz M (1993) Protein tyrosine kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes. J Immunol 151:6692–6700

    CAS  PubMed  Google Scholar 

  29. Nagy G, Koncz A, Fernandez D et al (2007) Nitric oxide, mitochondrial hyperpolarization, and T cell activation. Free Radic Biol Med 42:1625–1631

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  30. Chae HJ, Park RK, Chung HT et al (1997) Nitric oxide is a regulator of bone remodelling. J Pharm Pharmacol 49:897–902

    Article  CAS  PubMed  Google Scholar 

  31. Miesel R, Murphy MP, Kröger H (1996) Enhanced mitochondrial radical production in patients with rheumatoid arthritis correlates with elevated levels of tumor necrosis factor alpha in plasma. Free Radic Res 25:161–169

    Article  CAS  PubMed  Google Scholar 

  32. Neve A, Corrado A, Cantatore FP (2011) Osteoblast physiology in normal and pathological conditions. Cell Tissue Res 343:289–302

    Article  CAS  PubMed  Google Scholar 

  33. Pettit AR, Walsh NC, Manning C et al (2006) RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis. Rheumatology (Oxford) 45:1068–1076

    Article  CAS  Google Scholar 

  34. Gravallese EM, Harada Y, Wang JT et al (1998) Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol 152:943–951

    CAS  PubMed Central  PubMed  Google Scholar 

  35. Pettit AR, Ji H, von Stechow D et al (2001) TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am J Pathol 159:1689–1699

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  36. Kong YY, Feige U, Sarosi I et al (1999) Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402:304–309

    Article  CAS  PubMed  Google Scholar 

  37. Redlich K, Hayer S, Maier A et al (2002) Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin. Arthritis Rheum 46:785–792

    Article  CAS  PubMed  Google Scholar 

  38. Lubberts E, van den Bersselaar L, Oppers-Walgreen B et al (2003) IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance. J Immunol 170:2655–2662

    Article  CAS  PubMed  Google Scholar 

  39. Corrado A, Neve A, Macchiarola A, Gaudio A, Marucci A, Cantatore FP (2013) RANKL/OPG ratio and DKK-1 expression in primary osteoblastic cultures from osteoarthritic and osteoporotic subjects. J Rheumatol 40:684–694

    Article  CAS  PubMed  Google Scholar 

  40. Thomas GP, Baker SU, Eisman JA, Gardiner EM (2001) Changing RANKL/OPG mRNA expression in differentiating murine primary osteoblasts. J Endocrinol 170:451–460

    Article  CAS  PubMed  Google Scholar 

  41. Takasu H (2008) Anti-osteoclastogenic action of active vitamin D. Nutr Rev 66(10 Suppl 2):S113–S115

    Article  PubMed  Google Scholar 

  42. Maruotti N, Grano M, Colucci S et al (2011) Osteoclastogenesis and arthritis. Clin Exp Med 11:137–145

    Article  CAS  PubMed  Google Scholar 

  43. Fuller K, Murphy C, Firstein B, Fox SW, Chambers TJ (2002) TNFalpha potently activates osteoclasts, though a direct action independent and strongly synergistic with RANKL. Endocrinology 143:1108–1118

    CAS  PubMed  Google Scholar 

  44. Luo J, Wen H, Guo H, Cai Q, Li S, Li X (2013) 1,25-Dihydroxyvitamin D3 inhibits the RANKL pathway and impacts on the production of pathway-associated cytokines in early rheumatoid arthritis. Biomed Res Int 2013:101805. doi:10.1155/2013/101805 [Epub 2013 Apr 22]

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Rheumatology Clinic, Department of Medical and Surgical Sciences, University of Foggia, Ospedale “Col. D’Avanzo”, V.le degli Aviatori 1, 71100, Foggia, Italy

    Anna Neve, Addolorata Corrado & Francesco Paolo Cantatore

Authors
  1. Anna Neve
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Addolorata Corrado
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Francesco Paolo Cantatore
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Francesco Paolo Cantatore.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Neve, A., Corrado, A. & Cantatore, F.P. Immunomodulatory effects of vitamin D in peripheral blood monocyte-derived macrophages from patients with rheumatoid arthritis. Clin Exp Med 14, 275–283 (2014). https://doi.org/10.1007/s10238-013-0249-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10238-013-0249-2

Keywords

Search

Navigation